Crossmark

Microenvironmental regulation of solid tumour resistance to CAR T cell therapy

Published Online: 2025-10-14

Authors

Lamplugh, Zachary L.

Wellhausen, Nils

June, Carl H. https://orcid.org/0000-0003-0241-3557
Fan, Yi https://orcid.org/0000-0002-6290-0595
License Information

Text and Data Mining valid from 2025-10-14

Version of Record valid from 2025-10-14
More Information

Article History

Accepted: 10 September 2025

First Online: 14 October 2025

Competing interests

: C.H.J. is an inventor of patents and/or patent applications licensed to Novartis Institutes of Biomedical Research and receives licence revenue from such licences; is an inventor on patents and/or patent applications licensed to Kite Pharma, Capstan Therapeutics, Dispatch Therapeutics and BlueWhale Bio; and is a member of the scientific advisory boards of AC Immune, BluesphereBio, BlueWhale Bio, Cabaletta, Carisma, Cartography, Cellares, Celldex, Decheng, Replay Bio, Verismo and WIRB-Copernicus. Y.F. is a co-founder of Radix Therapeutics. The other authors declare no competing interests.

Document is current